Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
  • POSTS

Member profile

My Profile expand-item-icon-hover New Post

Skilvest

  • Blog posts

Cereno Scientific - Stor uppvärdering 2021?

SK
Skilvest

2021-01-04
0 comments

Cereno Scientific är bolaget med den blygsamma värderingen trots sina två fas II program varav det ena med särläkemedelsstatus (Orphan drug designation) samt flertalet pre-kliniska kandidater. Med säk...

Cereno Scientific

Prolight Diagnostics - Ett steg kvar till miljardmarknad

SK
Skilvest

2020-12-10
0 comments

Många patienter på akutmottagningar som söker vård för sina bröstsmärtor genomgår ett blodprovstest för att mäta nivåerna av Troponin vilket är ett ämne som utsöndras vid en eventuell hjärtinfarkt. I...

Prolight Diagnostics

Redeye community rules

The Redeye community members are responsible for their content. As a reader, you’re encouraged to critically analyze the content and do your own research. Before posting or commenting, please review our Rules & Guidelines

Top posts last week

  • Bubblan ingen vill spräcka 2021-01-17 labull
  • Prostalund - Nu en game-changer på en mångmiljard marknad 2021-01-19 appelbrand
  • Framtidens "gröna" supermaterial från Svenska Aerogel - Quartzene! 2021-01-15 eatsleepmakemoneyrepeat


Top authors last week

  • LA
    labull  
  • AP
    appelbrand  
  • eatsleepmakemoneyrepeat's avatar
    eatsleepmakemoneyrepeat  
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2021